Advertisement
Videos
Advertisement

Avandia: FDA May Reverse Restrictions

Thu, 06/06/2013 - 8:57am

Once the top-selling diabetes pill in the world, Avandia was severely restricted by the Food and Drug Administration after reports that taking the drug could raise the risk of heart attack. But now, the agency may be on the verge of reversing those restrictions.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading